Androgen Receptor Gene Overexpression Terminated Phase 2 Trials for Prasterone (DB01708)

IndicationStatusPhase
DBCOND0067050 (Androgen Receptor Gene Overexpression)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02000375A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)Treatment